Gesamtlänge aller Episoden: 3 days 20 hours 9 minutes
January 2009 Highlights: bipolar disorder and ADHD diagnosis in children; placebo response in antidepressant trials; neuroanatomy of ADHD; brain dysfunction in ADHD versus conduct disorder; repeat incarcerations for prisoners with serious mental illness.
December 2008 Highlights: prison inmates with ADHD; sleep disturbance and depression; circadian rhythms in pregnancy and postpartum; trauma and resilience in a high-risk population; GABA marker deficits in schizophrenia.
November 2008 Highlights: culture in psychodynamic psychotherapy; antipsychotics for adolescents; naltrexone for amphetamine dependence; bereavement-related depression; influence of cortisol and apolipoprotein E interaction on cognitive function.
October 2008 Highlights: drug treatment of breast cancer and depression; olanzapine for low body weight in anorexia; compulsive hoarding; adjunctive aripiprazole in bipolar mania; comparing PTSD criteria sets for diagnosis in children.
September 2008 Highlights: Body dysmorphic disorder treatment, parental mood disorders and treatment on child psychopathology outcomes, nicotine dependence risk, alcohol dependence remission, genome screen for schizophrenia and neurocognitive phenotypes.
August 2008 Highlights: Diagnosis and treatment of Asberger’s, new schizophrenia treatments, aripiprazole pharmacokinetics, schizophrenia functional impairment and frontal lobe dysfunction.
July 2008 Highlights: Clozapine treatment after development of neutropenia, antipsychotic treatment of Alzheimer’s disease symptoms, treatment decision tree for depression in elderly patients, possible physiologic marker of panic disorder.
June 2008 Highlights: Deep brain stimulation and cingulotomy; economic impact of mental disorders; adolescents with disruptive behavior disorders; comparison of atomoxetine and methylphenidate for ADHD; memory impairment and history of depression.
May 2008 Highlights: depression and comorbid chronic illness, cost-effectiveness of adolescent depression treatment, ADHD treatment and substance abuse, long-term borderline personality disorder treatment.
April 2008 Highlights: supportive psychotherapy; continuation fluoxetine in children; borderline personality group treatment; cannabis use and brain volume loss in schizophrenia; nicotine dependence and striatal dopamine D2 receptor availability.